CRISPR Genome Editing Advances Disease Modeling
In this Biocompare article, reporter Caitlin Smith highlights the transformative impact of CRISPR-Cas9 genetic editing on disease modeling, emphasizing its precision in altering genes within single cells, an advancement that accelerates research into disease mechanisms, drug screening, and therapeutics.
Rebecca Kreipke, senior workflow innovation and solutions specialist at Molecular Devices, underscores the importance of tools like high-speed imaging and high-content screening systems in verifying CRISPR edits and tracking their effects on cellular behavior. Kreipke also highlights the role of automation in drug screening, enabling researchers to make informed decisions quickly and advance the development of cell and gene therapies.